<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Laparoscopic gastrectomy for cancer
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Laparoscopic gastrectomy for cancer
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Laparoscopic gastrectomy for cancer
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joyce Wong, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David I Soybel, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 08, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3638818782">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastrectomy for adenocarcinoma via an open abdominal approach (OG) has been performed since the 1920s. Laparoscopic gastrectomy (LG) was first described in Japan in 1994, where a distal gastrectomy with Billroth I gastroduodenostomy reconstruction was performed for an early-stage gastric cancer [
         <a href="#rid1">
          1
         </a>
         ]. Since then, surgical experience with LG has been increasing, particularly in Eastern countries such as Japan, Korea, and China, where gastric adenocarcinoma is more prevalent.
        </p>
        <p>
         The indications, patient selection, surgical techniques, postoperative care, and outcomes of LG for cancer are discussed in this topic. OG and LG for benign diseases (eg, peptic ulcer) or weight loss are discussed in other topics. (See
         <a class="medical medical_review" href="/z/d/html/8040.html" rel="external">
          "Surgical management of peptic ulcer disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15161.html" rel="external">
          "Partial gastrectomy and gastrointestinal reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15166.html" rel="external">
          "Total gastrectomy and gastrointestinal reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88536.html" rel="external">
          "Bariatric procedures for the management of severe obesity: Descriptions"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3892592126">
         <span class="h1">
          EASTERN VERSUS WESTERN EXPERIENCE
         </span>
        </p>
        <p class="headingAnchor" id="H2545557261">
         <span class="h2">
          Eastern experience
         </span>
         <span class="headingEndMark">
          —
         </span>
         LG is a well-established technique for treating gastric cancer in Eastern countries. According to national surveys, LG accounted for approximately 25 percent of all gastric surgeries performed for cancer in Japan and South Korea as early as 2009 [
         <a href="#rid2">
          2
         </a>
         ]. The efficacy of LG has been demonstrated for both early and locally advanced gastric cancers in Eastern countries [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2186314145">
         <span class="h3">
          Early gastric cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early gastric cancer is defined as invasive gastric cancer that invades no more deeply than the submucosa, regardless of lymph node metastasis (T1, any N, M0)  (
         <a class="graphic graphic_table graphicRef111190" href="/z/d/graphic/111190.html" rel="external">
          table 1
         </a>
         ). Early gastric cancer is of particular importance to patients in East Asia, where it accounts for 25 to 50 percent of all gastric cancers diagnosed because of screening programs. (See
         <a class="medical medical_review" href="/z/d/html/2520.html" rel="external">
          "Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging"
         </a>
         .)
        </p>
        <p>
         An early Japanese study involving 1294 patients undergoing LG (91.5 percent distal gastrectomy) for gastric cancer from 1994 to 2003 showed mortality and morbidity rates of 0 and 14.8 percent and a recurrence rate of 0.6 percent at a median follow-up of three years [
         <a href="#rid4">
          4
         </a>
         ]. The five-year disease-free survival rate was 99.8 percent for stage IA disease, 98.7 percent for stage IB disease, and 85.7 percent for stage II disease.
        </p>
        <p>
         A subsequent Japanese study (LOC-1) compared the outcomes of 3630 patients with early gastric cancer treated with LG or open gastrectomy (OG) from 2006 to 2012 [
         <a href="#rid5">
          5
         </a>
         ]. By propensity score-matched analysis, there was no difference in five-year overall survival (97.1 percent LG versus 96.3 percent OG), three-year recurrence-free survival (97.7 versus 97.4 percent), or local recurrence rate (2.3 versus 2.4 percent).
        </p>
        <p>
         In a Korean trial (KLASS-1), over 1400 patients with stage I early gastric cancer were randomly assigned to either open or laparoscopic distal gastrectomy between 2006 and 2010 [
         <a href="#rid6">
          6
         </a>
         ]. The overall complication rate (13 versus 20 percent) and wound complication rate (3.6 versus 7 percent) were lower in the LG group. Major intra-abdominal complication and perioperative mortality rates were similar between the two groups. At five years, the overall (94.2 percent LG and 93.3 percent OG) and cancer-specific survival rates (97.1 percent LG and 97.2 percent OG) were not different between the two groups either [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Another large trial from Japan (JCOG0912) randomly assigned 921 patients with clinical stage I gastric cancer in the middle or lower third of the stomach to either LG or OG from 2010 to 2013 [
         <a href="#rid8">
          8
         </a>
         ]. Compared with OG, LG required longer operative time but had less blood loss. Otherwise, there was no difference in short-term morbidity and mortality rates. The five-year relapse-free survival was 94 percent (95% CI 91.4-95.9) in the OG group and 95.1 percent (95% CI 92.7-96.8) in the LG group [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         With respect to proximal gastric cancers, an ongoing multicenter prospective Korean trial (KLASS-03) has established the feasibility and safety of laparoscopic total gastrectomy in early-stage gastric cancers [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Similarly, in a multicenter trial from China (CLASS02), in which 214 patients with clinical stage I gastric cancer underwent laparoscopic or open total gastrectomy, the perioperative morbidity and mortality rates were not significantly different between the two groups (laparoscopic 18.1 and 1 percent; open 17.4 and 0 percent) [
         <a href="#rid11">
          11
         </a>
         ]. Laparoscopic total gastrectomy was associated with longer operative time but less blood loss. Further follow-up is needed to establish the long-term oncologic safety of the laparoscopic approach in proximal gastric cancers.
        </p>
        <p class="headingAnchor" id="H2578770416">
         <span class="h3">
          Locally advanced gastric cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Locally advanced gastric cancer invades deeper than the submucosa, regardless of lymph node metastasis (≥T2, any N, M0)  (
         <a class="graphic graphic_table graphicRef111190" href="/z/d/graphic/111190.html" rel="external">
          table 1
         </a>
         ). As their experience with LG for early gastric cancer grew, Eastern surgeons began to treat locally advanced gastric cancers with LG as well. In particular, the paucity of early gastric cancer and abundance of locally advanced gastric cancer in China (relative to Japan and Korea) prompted surgeons there to pursue LG for locally advanced gastric cancers [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         In a retrospective study of over 1100 patients in China who underwent LG for stage I, II, or III gastric cancer between 2003 and 2009, perioperative morbidity and mortality rates were 10 and 0.1 percent, overall and locoregional recurrence rates were 16.7 and 2.3 percent, and survival at a median follow-up of 12 months varied between 60 and 90 percent, depending on disease stage [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         In a Chinese trial (CLASS-01) conducted from 2012 to 2014, over 1000 patients with locally advanced gastric cancer (T2-4, N0-3, M0) were randomly assigned to either LG or OG, both including a D2 lymphadenectomy [
         <a href="#rid14">
          14
         </a>
         ]. LG and OG resulted in similar perioperative morbidity (15 versus 13 percent) and mortality rates (0.4 versus 0 percent) as well as compliance rates of D2 lymphadenectomy (both &gt;99 percent). At three years, LG and OG resulted in similar overall survival (83 versus 85 percent), disease-free survival (77 versus 78 percent), and cumulative recurrence rates (19 versus 17 percent) [
         <a href="#rid15">
          15
         </a>
         ]. At five years, LG and OG again resulted in similar overall survival (73 versus 76 percent) [
         <a href="#rid16">
          16
         </a>
         ]. The CLASS-01 study demonstrated that when performed by experienced surgeons, laparoscopic distal gastrectomy with D2 lymphadenectomy is safe and effective for clinically staged locally advanced gastric cancers. However, about one-third of patients were overstaged and had pathologic stage I tumors. None of the patients received neoadjuvant therapy, contrary to what is typically recommended in Western patients. Additionally, since most Western patients predominantly require proximal as opposed to distal gastrectomy, these results may be limited in applicability to a Western population.
        </p>
        <p>
         Similarly, in a Korean trial (KLASS-02-RCT) conducted from 2011 to 2015, over 1000 patients with cT2-4a, N0-1 gastric adenocarcinoma were randomly assigned to either LG or OG, both with D2 lymphadenectomy [
         <a href="#rid17">
          17
         </a>
         ]. LG resulted in a lower 30 day morbidity rate (16.6 versus 24.1 percent), lower patient-reported pain score, less postoperative analgesic use, earlier passage of flatus, and shorter hospital stay (8.1 versus 9.3 days) than OG. The mean number of lymph nodes retrieved and 90 day mortality rate were comparable between the two groups. At three years, relapse-free survivals were also comparable between the two groups (80.3 percent LG, 81.3 percent OG) [
         <a href="#rid18">
          18
         </a>
         ]. At five years, relapse-free survivals remained comparable (79.5 percent LG, 81.1 percent OG) and late complications (eg, intestinal obstruction) were less frequent after LG (6.5 percent LG, 11 percent OG) [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         One other trial, JLSSG0901 from Japan [
         <a href="#rid20">
          20
         </a>
         ], is currently ongoing to evaluate the efficacy of LG for locally advanced gastric cancer.
        </p>
        <p class="headingAnchor" id="H1426999265">
         <span class="h2">
          Western experience
         </span>
         <span class="headingEndMark">
          —
         </span>
         Compared with Eastern countries, LG is underutilized in Western countries. An analysis of the University Health System Consortium database demonstrated that 89.5, 8.2, and 2.3 percent of over 9500 gastrectomies were performed open, laparoscopically, and robotically from 2008 to 2013 [
         <a href="#rid21">
          21
         </a>
         ]. Another analysis of the United States National Cancer Database showed that 73.4, 23.1, and 3.5 percent of over 6400 gastrectomies for cancer were performed open, laparoscopically, and robotically between 2010 and 2012 [
         <a href="#rid22">
          22
         </a>
         ]. Limited by a lower prevalence of gastric cancer, fewer studies and only one randomized trial of LG have been conducted in Western countries.
        </p>
        <p>
         In the Dutch LOGICA trial, 227 patients with cT1-4a, N0-3b, M0 gastric cancer underwent OG or LG. LG resulted in less blood loss than open surgery but had a longer operative time. Otherwise, OG and LG did not differ in postoperative complication rate, in-hospital mortality rate, 30 day readmission rate, R0 resection rate, median lymph node yield, one-year overall survival rate, and global health-related quality of life up to one year postoperatively [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         In a study of 87 LGs and 87 matched OGs performed for stage I, II, or III gastric cancer from 2005 to 2013 at the Memorial Sloan Kettering Cancer Center, LG was associated with a longer operative time but shorter length of stay and fewer early and late complications [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         The same study using the National Cancer Database mentioned above showed LG to be associated with a shorter length of hospital stay (by one day), a greater lymph node yield (odds ratio 1.16 of having ≥15 nodes), and comparable negative margin and mortality rates compared with OG [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         Another European trial, Surgical Technique, Open versus Minimally Invasive Gastrectomy after Chemotherapy (STOMACH), randomly assigned 96 patients to either minimally invasive versus open total gastrectomy after receiving neoadjuvant chemotherapy from 2015 to 2018 [
         <a href="#rid25">
          25
         </a>
         ]. There was no difference in operative or postoperative outcomes, and similar one-year survival was seen between the two groups. This trial suggested the oncologically noninferior outcomes of a minimally invasive approach, but three-year results are pending.
        </p>
        <p class="headingAnchor" id="H1519274607">
         <span class="h2">
          East versus West
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinicopathological presentations of gastric cancer are known to vary widely between Eastern and Western countries. In a study comparing all patients undergoing curative resections (R0) for gastric cancer at two high-volume hospitals from the United States (US; 711 patients) and Korea (1646 patients), age and body mass index were significantly higher in US patients [
         <a href="#rid26">
          26
         </a>
         ]. The location of tumors was more often proximal in the US (39 versus 9 percent) and distal in Korea (54 versus 33 percent). Korean patients had more early-stage tumors (42 versus 28 percent stage IA) and a greater lymph node yield (97 versus 79 percent, ≥15 lymph nodes). With the exception of lymph node yield, all the other factors were potentially biased against US patients, which may at least partially explain why Eastern patients have a better survival rate than Western patients.
        </p>
        <p>
         There is also evidence that Eastern patients may have superior survival compared with Western patients on a stage-for-stage basis [
         <a href="#rid26">
          26,27
         </a>
         ]. However, it remains controversial whether the difference in survival is due to tumor biology; patient, genetic, and environmental factors; or treatment. There is no suggestion, however, that the survival is influenced by technical aspects such as the use of LG.
        </p>
        <p class="headingAnchor" id="H4178591148">
         <span class="h1">
          PATIENT SELECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies cited above suggest that LG is safe, feasible, and oncologically sound when performed by experienced surgeons in both Eastern and Western countries, although long-term randomized data have not yet been accrued. Whether to pursue LG or open gastrectomy (OG) depends on the following provider and patient factors.
        </p>
        <p class="headingAnchor" id="H3920423179">
         <span class="h2">
          Provider factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         LG is a technically demanding procedure that requires advanced skills and teamwork. The surgeon performing LG must be experienced with both complex gastrointestinal and advanced minimally invasive procedures and be supported by staff and hospital resources of equal competence.
        </p>
        <p class="headingAnchor" id="H1440876302">
         <span class="h3">
          Surgeon experience
         </span>
         <span class="headingEndMark">
          —
         </span>
         LG is a complex minimally invasive procedure. The learning curve associated with becoming proficient in performing LG, particularly the D2 lymphadenectomy and reconstruction portions of the operation, can be quite steep.
        </p>
        <p>
         Studies from Eastern countries estimated that surgeons would require at least between 40 and 60, and possibly over 90, cases of laparoscopic distal gastrectomy [
         <a href="#rid28">
          28-30
         </a>
         ], or over 100 cases of laparoscopic total gastrectomy [
         <a href="#rid31">
          31
         </a>
         ], to become proficient. In at least one study, performing fewer than 45 cases of laparoscopic total gastrectomy was associated with higher morbidity [
         <a href="#rid32">
          32
         </a>
         ]. There have been no studies on the learning curve of LG from Western countries.
        </p>
        <p class="headingAnchor" id="H3927976077">
         <span class="h3">
          Hospital resources
         </span>
         <span class="headingEndMark">
          —
         </span>
         An experienced surgeon needs to be supported by an operating room and anesthesia staff that is equally facile with handling advanced minimally invasive surgery. In the event that a complication occurs, additional support from critical care intensivists, therapeutic gastroenterologists, and interventional radiologists may be required. Expert physical therapy and nutritional support services are also imperative to good outcomes as many patients with gastric cancer come to surgery in frail or debilitated conditions, especially after receiving neoadjuvant chemotherapy.
        </p>
        <p class="headingAnchor" id="H3602889694">
         <span class="h2">
          Patient factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient-related factors, such as body habitus, comorbidities, and cancer stage, can also influence the choice of LG versus OG. Patients who have early gastric cancer and those who are free from significant cardiopulmonary comorbidities, obesity, and previous upper abdominal surgery are the best candidates for LG.
        </p>
        <p class="headingAnchor" id="H1627191901">
         <span class="h3">
          Comorbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with severe obstructive pulmonary disease (COPD) or cardiac disease may not tolerate the prolonged pneumoperitoneum that is often required for LG. Such patients should undergo OG instead.
        </p>
        <p class="headingAnchor" id="H977811886">
         <span class="h3">
          Obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity (body mass index ≥30 kg/m
         <sup>
          2
         </sup>
         ), or increased visceral adiposity, can make LG with D2 lymphadenectomy technically challenging. Studies from Eastern countries found that LG in patients with obesity may require longer operative times than OG, although lymph node yield, postoperative recovery, and complication rate were not different [
         <a href="#rid33">
          33-35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H940728785">
         <span class="h3">
          Previous abdominal surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Previous abdominal surgery may make LG technically challenging due to the presence of adhesions or altered anatomy. However, this factor alone should not preclude LG [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3929587685">
         <span class="h3">
          Disease extent
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with early-stage disease without local invasion into surrounding structures or bulky lymphadenopathy are optimal candidates for surgeons to initiate an LG experience. Patients with locally advanced tumors that downstage after neoadjuvant therapy and those who undergo prophylactic total gastrectomy for
         <em>
          CDH1
         </em>
         or other mutations may also be candidates for LG. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p>
         However, in the United States and other Western countries, patients often present in advanced stages of gastric cancer. Larger tumors and locally advanced tumors with clear invasion into adjacent organs are best resected with OG, which offers tactile feedback that is lacking in LG.
        </p>
        <p class="headingAnchor" id="H1528984104">
         <span class="h1">
          SURGICAL TECHNIQUES
         </span>
        </p>
        <p class="headingAnchor" id="H1039478236">
         <span class="h2">
          Laparoscopic total gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laparoscopic total gastrectomy is riskier and technically more demanding than laparoscopic distal gastrectomy because of the requirement of an esophagojejunostomy.
        </p>
        <p>
         The patient is placed in a supine or modified lithotomy position, depending upon surgeon preference. The author favors a five-port technique that involves three 12 mm ports and two 5 mm ports. Typically, the central 12 mm camera port is positioned at the level of the umbilicus or just above, depending upon the length of the torso  (
         <a class="graphic graphic_figure graphicRef111497" href="/z/d/graphic/111497.html" rel="external">
          figure 1
         </a>
         ). The patient is placed into a slight reverse Trendelenburg (head up) position.
        </p>
        <p>
         Assessment of the peritoneal cavity for micrometastatic disease is performed upon establishing pneumoperitoneum. If metastatic disease is identified and confirmed with frozen section biopsy, resection is aborted. (See
         <a class="medical medical_review" href="/z/d/html/15106.html" rel="external">
          "Diagnostic staging laparoscopy for digestive system cancers", section on 'Esophagogastric junction and gastric cancer'
         </a>
         .)
        </p>
        <p>
         The left lateral segment of the liver can then be retracted using one of the following techniques:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With a Diamond-Flex- or Nathanson-type retractor placed via a stab incision
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With a gauze that is retracted by a suture clipped to the pars flaccida of the gastrohepatic ligament and brought out the anterior abdominal wall
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         With a silicone disc (as described by Japanese surgeons) [
         <a href="#rid37">
          37,38
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         The gastrocolic ligament is then divided with LigaSure or a Harmonic scalpel. Dissection proceeds cephalad along the greater curvature of the stomach until all of the short gastric vessels have been divided, the fundus of the stomach is fully mobilized, and the left diaphragmatic crus is identified. Dissection then proceeds caudally along the distal aspect of the stomach toward the pylorus. The right gastroepiploic artery and vein are stripped of lymphatic tissue and divided either between clips or with a vascular stapler  (
         <a class="graphic graphic_figure graphicRef58218" href="/z/d/graphic/58218.html" rel="external">
          figure 2
         </a>
         ). This allows for skeletonization of the inferior aspect of the pylorus. The posterior wall of the stomach should be dissected off the anterior aspect of the pancreas  (
         <a class="graphic graphic_picture graphicRef111498" href="/z/d/graphic/111498.html" rel="external">
          picture 1
         </a>
         ). The gastroduodenal artery can be identified posterior to the pylorus, along the duodenum.
        </p>
        <p>
         The gastrohepatic ligament is then divided to facilitate dissection along the lesser curvature. The right gastric artery is divided at its insertion into the pylorus  (
         <a class="graphic graphic_figure graphicRef58218" href="/z/d/graphic/58218.html" rel="external">
          figure 2
         </a>
         ). The superior aspect of the pylorus is skeletonized and dissected free until it can be elevated off the pancreas; this may necessitate mobilization of the duodenal bulb superiorly from the retroperitoneum.
        </p>
        <p>
         The duodenum just distal to the pylorus is transected with an Endo GIA stapler. Retraction of the stomach inferiorly exposes the lesser sac space. The common hepatic artery is identified. The lymph nodes overlying the common hepatic artery are dissected free; this dissection proceeds distally until the takeoff of the gastroduodenal artery. With anterior elevation of the stomach, the left gastric artery is identified. The left gastric artery and vein are cleared of lymphatic tissue, and the vessels are divided close to the celiac axis. Similarly, the origin of the splenic artery is identified and cleared of lymphatic tissue.
        </p>
        <p>
         Once lymphadenectomy has been completed in the lesser sac space, the dissection proceeds along the lesser curvature cephalad toward the phrenoesophageal ligament. The right diaphragmatic crus is identified. The phrenoesophageal ligament is divided, and the esophagus is mobilized circumferentially. The esophagus just proximal to the gastroesophageal junction is transected with an Endo GIA stapler  (
         <a class="graphic graphic_picture graphicRef111499" href="/z/d/graphic/111499.html" rel="external">
          picture 2
         </a>
         ), and the entire stomach is placed into a specimen bag and retrieved. The author favors performing frozen section analysis of the proximal margin. An omentectomy is also performed prior to reconstruction of the alimentary tract.
        </p>
        <p>
         The jejunum is transected 20 to 30 cm distal to the ligament of Treitz. The distal end should be able to reach the esophageal stump without tension, in an antecolic fashion. Esophagojejunostomy reconstruction can be performed either handsewn or with a circular EEA stapler. The author utilizes an EEA stapler with an anvil that is passed transorally (the OrVil device). The staple line to the distal jejunal stump is removed to allow insertion of the stapler handle. After the spike of the stapler is driven through the jejunal bowel wall, it is connected with the anvil and the stapler fired to create a circular anastomosis  (
         <a class="graphic graphic_picture graphicRef111500" href="/z/d/graphic/111500.html" rel="external">
          picture 3
         </a>
         and
         <a class="graphic graphic_picture graphicRef111501" href="/z/d/graphic/111501.html" rel="external">
          picture 4
         </a>
         ). The stapler handle is removed, and the jejunotomy is closed with an additional firing of the Endo GIA stapler, creating a small jejunal pouch distal to the anastomosis  (
         <a class="graphic graphic_figure graphicRef63448" href="/z/d/graphic/63448.html" rel="external">
          figure 3
         </a>
         and
         <a class="graphic graphic_figure graphicRef111476" href="/z/d/graphic/111476.html" rel="external">
          figure 4
         </a>
         ). A 50 to 60 cm Roux limb is measured, and a side-to-side jejunojejunostomy is created with an Endo GIA stapler. Distal to that, a feeding jejunostomy tube is often placed, in accordance with surgeon preference.
        </p>
        <p class="headingAnchor" id="H557363444">
         <span class="h2">
          Laparoscopic distal gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A laparoscopic distal gastrectomy is performed with similar ports and liver retraction methods to those of a laparoscopic total gastrectomy. Depending on the location of the tumor, it may not be necessary to completely mobilize the fundus or divide the left gastric artery. The stomach is transected with the aim of achieving a 5 cm gross margin in the proximal stomach. After a similar lymphadenectomy and omentectomy have been performed, the gastrointestinal tract is reconstructed with a Billroth II gastrojejunostomy or Roux-en-Y gastrojejunostomy  (
         <a class="graphic graphic_figure graphicRef89669" href="/z/d/graphic/89669.html" rel="external">
          figure 5
         </a>
         ). Feeding tubes are typically not required for distal gastrectomy.
        </p>
        <p>
         Step-by-step guidance for a robotic distal subtotal gastrectomy with D2 lymphadenectomy procedures has been created [
         <a href="#rid39">
          39
         </a>
         ]. It contains short video clips of 20 key steps of a standardized procedure and can be displayed on the robotic console intraoperatively in real time for mentoring purposes.
        </p>
        <p class="headingAnchor" id="H64846284">
         <span class="h2">
          Laparoscopic pylorus preserving gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pylorus-preserving gastrectomy (PPG) was originally used for peptic ulcer disease but has since been adapted in East Asia to treat early gastric cancer located in the middle third of the stomach, &gt;5 cm from the pylorus. It is oncologically safe as the risk of metastasis to the suprapyloric lymph nodes is very low [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         In the KLASS-4 trial, patients who underwent laparoscopic PPG and laparoscopic distal gastrectomy had similar short-term outcomes [
         <a href="#rid41">
          41
         </a>
         ]. A separate nonrandomized Korean study analyzed 288 patients undergoing gastrectomy for early gastric cancer from 2013 to 2016; 145 underwent PPG. Compared with other resection types, PPG was associated with narrower surgical margins and fewer total numbers of resected lymph nodes but similar incidences of delayed gastric emptying and similar three-year recurrence-free survivals. The PPG group also showed a lower decrease in body weight and body mass index at 6 and 12 months [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1998077932">
         <span class="h2">
          Laparoscopic proximal gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         First described in 1995 [
         <a href="#rid43">
          43
         </a>
         ], laparoscopic proximal gastrectomy is an alternative to total gastrectomy for patients with proximal gastric cancer that may offer them better long-term nutritional outcomes.
        </p>
        <p>
         To mitigate potentially significant postoperative reflux that can occur following proximal gastrectomy, many reconstruction techniques have been devised, including esophagogastrostomy, esophagogastrostomy with gastric tube creation, esophagogastrostomy with fundoplication, esophagojejunostomy with jejunal interposition, and esophagojejunostomy with double tract reconstruction [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         Based on limited series, patient nutrition status does seem to improve with proximal gastrectomy compared with total gastrectomy, while short-term surgical and oncologic outcomes appear similar [
         <a href="#rid45">
          45,46
         </a>
         ]. Further studies with more patients and longer follow-up are needed to determine the role of proximal gastrectomy in the treatment of proximal gastric cancer.
        </p>
        <p class="headingAnchor" id="H3837708486">
         <span class="h1">
          POSTOPERATIVE CARE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following LG, patients are admitted to the regular surgical floor unless more intensive monitoring is required. Enhanced recovery programs for minimally invasive procedures should be followed, with emphasis on early mobilization and preference for non-narcotic analgesia [
         <a href="#rid47">
          47,48
         </a>
         ]. Compared with conventional care, enhanced recovery programs were associated with earlier time to ambulation and oral intake, shorter length of hospital stay, and comparable morbidity and mortality [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         It is the author's practice to routinely use prophylactic nasogastric tube decompression following total gastrectomy but not following distal gastrectomy. In total gastrectomy, the nasogastric tube is placed across the esophagojejunostomy as a transanastomotic "stent"; the tube is typically removed following a negative swallow study performed on postoperative day 4 or 5. A swallow test is not routinely performed in patients undergoing distal gastrectomy.
        </p>
        <p>
         Diet is typically advanced as tolerated from postoperative day 1 or 2 following distal gastrectomy and following a negative swallow study for those undergoing total gastrectomy.
         <strong>
         </strong>
         Because oral intake is often not enough to sustain hydration and nutrition after a total gastrectomy, the author initiates trickle jejunal tube feeding 24 hours after surgery with slow advancement until the combination of oral intake and jejunal tube feeding becomes sufficient to sustain hydration and nutrition.
        </p>
        <p>
         Once the patient is taking in sufficient oral intake to maintain body weight, the jejunal feeding tube can be removed in the office. By contrast, surgeons in the East largely avoid using feeding tubes, even in total gastrectomy patients.
        </p>
        <p class="headingAnchor" id="H1898550978">
         <span class="h1">
          OUTCOMES
         </span>
        </p>
        <p>
         In Eastern countries, LG has been compared with open gastrectomy (OG) in multiple randomized trials (see
         <a class="local">
          'Eastern experience'
         </a>
         above). A 2016 systematic review and meta-analysis of 14 such trials including over 2000 patients concluded that [
         <a href="#rid49">
          49
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         LG resulted in less blood loss; shorter time to first flatus, first walking, and first oral intake; reduced frequency of analgesic administration; shorter hospital stay; and reduced overall postoperative morbidity.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There was no difference in number of retrieved lymph nodes, mortality, recurrence, long-term overall survival, and disease-free survival between LG and OG.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         LG was associated with higher patient satisfaction and quality of life.
        </p>
        <p>
        </p>
        <p>
         A 2022 systematic review and meta-analysis of 22 randomized trials (20 of which were from Eastern countries) reached the same conclusions [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         A prospective study from Korea with an emphasis on quality of life found LG to be superior to OG [
         <a href="#rid51">
          51
         </a>
         ]. Specifically, patients reported better global health and functional quality of life; less appetite loss, pain, and reflux; fewer emotional problems; and improved body image at three months after LG compared with after OG.
        </p>
        <p>
         Continued follow-up of the same group of patients, however, showed that the differences in quality of life mostly disappeared by approximately 24 months after surgery, with two exceptions: the dysphagia symptom score remained higher in the OG group, and the dyspnea symptom score remained higher in the LG group [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Using propensity score matching, a study of over 17,000 patients from the National Cancer Database (NCDB) between 2010 and 2015 found that minimally invasive gastrectomy was associated with improved five-year survival (51.9 versus 47.7 percent, p&lt;0.0001) compared with open gastrectomy [
         <a href="#rid53">
          53
         </a>
         ]. There was no difference between laparoscopic and robotic approaches.
        </p>
        <p class="headingAnchor" id="H3392903337">
         <span class="h1">
          MINIMALLY INVASIVE ALTERNATIVES
         </span>
        </p>
        <p class="headingAnchor" id="H3134045317">
         <span class="h2">
          Robotic surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since the early 2000s, robotic gastric surgery has emerged as an alternative minimally invasive technique to LG. However, in Western countries such as the United States and countries in Europe, robotic gastric surgery remains an emerging rather than established technology.
        </p>
        <p>
         Compared with conventional LG, robotic gastric surgery has the advantages of three-dimensional high-definition visualization, wristed and articulated movements, and improved ergonomics, with the surgeon able to sit during the operation. The cost of the robotic platform is higher than with laparoscopy, and operative times are typically longer.
        </p>
        <p>
         The robotic platform also permits near-infrared fluorescent visualization, which can be used to guide lymph node dissection [
         <a href="#rid54">
          54,55
         </a>
         ]. In small studies, this technique has yielded greater numbers of lymph nodes overall or at certain lymph node stations. However, it is unclear if a more extended lymph node dissection will translate into better cancer-specific survival.
        </p>
        <p>
         Robotic gastric surgery has been compared with LG in both Eastern and Western series [
         <a href="#rid22">
          22,56-60
         </a>
         ]. In a systematic review and meta-analysis of 12 studies including over 3500 patients, robotic gastric surgery was associated with less blood loss, less time to first flatus, and greater lymph node yield than conventional LG [
         <a href="#rid61">
          61
         </a>
         ]. Robotic gastric resection was also associated with shorter hospital stay but longer operative time. Robotic gastric resection and LG had similar postoperative morbidity, mortality, and conversion rates.
        </p>
        <p>
         A Chinese trial compared robotic distal gastrectomy (RDG) with laparoscopic distal gastrectomy (LDG) in 283 patients with gastric cancer [
         <a href="#rid62">
          62
         </a>
         ]. Although total surgical duration was longer with RDG, intraoperative blood loss was significantly less. Postoperative length of stay was similar between the two groups. Although the total number of examined lymph nodes was similar between the groups, dissection of certain lymph node stations was improved with RDG. Patients undergoing RDG also seemed to be able to initiate adjuvant chemotherapy earlier than those in the LDG group.
        </p>
        <p>
         A Japanese single-institution phase III trial randomly assigned 241 patients with resectable gastric cancer to either laparoscopic (LG) or robotic gastrectomy (RG) [
         <a href="#rid63">
          63
         </a>
         ]. The overall incidence of postoperative complications of grade II or higher was significantly higher in the LG group than the RG group (19.7 versus 8.8 percent), and so was the complication rate of grade IIIa or higher (16.2 versus 5.3 percent). However, the intra-abdominal infectious complication rates were similar between LG and RG.
        </p>
        <p class="headingAnchor" id="H2534148458">
         <span class="h2">
          Endoscopic resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic resection and combined endoscopic-laparoscopic resection are other minimally invasive options for treating early-stage gastric cancer. (See
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors"
         </a>
         .)
        </p>
        <p>
         Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have been widely used in Eastern countries to treat early gastric cancer. A common indication is for well-differentiated, nonulcerated mucosal lesions &lt;2 cm [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors", section on 'Gastric cancer'
         </a>
         .)
        </p>
        <p>
         Endoscopic resection is highly operator dependent in achieving negative margins with an adequate resection. Although more liberal uses of endoscopic resection have been advocated [
         <a href="#rid65">
          65,66
         </a>
         ], studies with longer follow-up, particularly in the United States and Europe, are required before new indications become widely accepted.
        </p>
        <p class="headingAnchor" id="H1315383453">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114875.html" rel="external">
          "Society guideline links: Gastric cancer"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/116783.html" rel="external">
          "Society guideline links: Laparoscopic and robotic surgery"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/134311.html" rel="external">
          "Society guideline links: Gastric surgery for cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H509810312">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Requirements for laparoscopic gastrectomy
         </strong>
         – The surgeon performing laparoscopic gastrectomy (LG) must be experienced with both complex gastrointestinal and advanced minimally invasive procedures and be supported by staff and hospital resources of equal competence. Patients with early gastric cancer who are free of significant cardiopulmonary comorbidities, obesity, and previous upper abdominal surgery are the best candidates for LG. (See
         <a class="local">
          'Patient selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laparoscopic total gastrectomy
         </strong>
         – Laparoscopic total gastrectomy requires port placement, liver retraction, dissection along the greater and lesser curvature of the stomach, lymphadenectomy, vascular division, duodenal and esophageal transection, and esophagojejunostomy reconstruction. (See
         <a class="local">
          'Laparoscopic total gastrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laparoscopic distal gastrectomy
         </strong>
         – Laparoscopic distal gastrectomy follows the same general steps of a total gastrectomy but may not require full mobilization of the fundus or division of the left gastric artery depending on the location of the tumor. A gross margin of 5 cm in the proximal stomach is required. Reconstruction is typically by a Billroth II gastrojejunostomy or Roux-en-Y gastrojejunostomy. (See
         <a class="local">
          'Laparoscopic distal gastrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative care
         </strong>
         – Enhanced recovery programs for minimally invasive procedures should be followed, with emphasis on early mobilization and preference for non-narcotic analgesia. In the author's practice, nasogastric tube decompression across the anastomosis and jejunal tube feeding are routinely used after total but not distal gastrectomy. (See
         <a class="local">
          'Postoperative care'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcomes
         </strong>
         – Compared with open gastrectomy (OG), LG has superior or equal short-term patient outcomes and comparable long-term oncologic outcomes. Patients undergoing LG also report a better quality of life in the early postoperative period, but the difference disappears after two years. (See
         <a class="local">
          'Outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Minimally invasive alternatives to laparoscopic gastrectomy
         </strong>
         – Alternative minimally invasive techniques of treating gastric cancer include robotic gastric resection and endoscopic resection. (See
         <a class="local">
          'Minimally invasive alternatives'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994; 4:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Son SY, Kim HH. Minimally invasive surgery in gastric cancer. World J Gastroenterol 2014; 20:14132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aiolfi A, Lombardo F, Matsushima K, et al. Systematic review and updated network meta-analysis of randomized controlled trials comparing open, laparoscopic-assisted, and robotic distal gastrectomy for early and locally advanced gastric cancer. Surgery 2021; 170:942.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitano S, Shiraishi N, Uyama I, et al. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg 2007; 245:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honda M, Hiki N, Kinoshita T, et al. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann Surg 2016; 264:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim W, Kim HH, Han SU, et al. Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01). Ann Surg 2016; 263:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HH, Han SU, Kim MC, et al. Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncol 2019; 5:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katai H, Mizusawa J, Katayama H, et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912. Gastric Cancer 2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol 2020; 5:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyung WJ, Yang HK, Han SU, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03. Gastric Cancer 2019; 22:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu F, Huang C, Xu Z, et al. Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial. JAMA Oncol 2020; 6:1590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Z, Shan F, Wang Y, et al. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results. Surg Endosc 2016; 30:4265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu Y, Ying M, Huang C, et al. Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China. Surg Endosc 2014; 28:2048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu Y, Huang C, Sun Y, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. J Clin Oncol 2016; 34:1350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu J, Huang C, Sun Y, et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. JAMA 2019; 321:1983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang C, Liu H, Hu Y, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg 2022; 157:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HJ, Hyung WJ, Yang HK, et al. Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT). Ann Surg 2019; 270:983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hyung WJ, Yang HK, Park YK, et al. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial. J Clin Oncol 2020; 38:3304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Son SY, Hur H, Hyung WJ, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial. JAMA Surg 2022; 157:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inaki N, Etoh T, Ohyama T, et al. A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901). World J Surg 2015; 39:2734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glenn JA, Turaga KK, Gamblin TC, et al. Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers. Surg Endosc 2015; 29:3768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenleaf EK, Sun SX, Hollenbeak CS, Wong J. Minimally invasive surgery for gastric cancer: the American experience. Gastric Cancer 2017; 20:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Veen, Brenkman HJF, Seesing MFJ, et al. Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial. J Clin Oncol 2021.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelly KJ, Selby L, Chou JF, et al. Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study. Ann Surg Oncol 2015; 22:3590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Wielen N, Straatman J, Daams F, et al. Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer 2021; 24:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strong VE, Song KY, Park CH, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010; 251:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strong VE, Song KY, Park CH, et al. Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol 2013; 107:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HG, Park JH, Jeong SH, et al. Totally laparoscopic distal gastrectomy after learning curve completion: comparison with laparoscopy-assisted distal gastrectomy. J Gastric Cancer 2013; 13:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moon JS, Park MS, Kim JH, et al. Lessons learned from a comparative analysis of surgical outcomes of and learning curves for laparoscopy-assisted distal gastrectomy. J Gastric Cancer 2015; 15:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HH, Han SU, Kim MC, et al. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol 2014; 32:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung DH, Son SY, Park YS, et al. The learning curve associated with laparoscopic total gastrectomy. Gastric Cancer 2016; 19:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jeong O, Ryu SY, Choi WY, et al. Risk factors and learning curve associated with postoperative morbidity of laparoscopic total gastrectomy for gastric carcinoma. Ann Surg Oncol 2014; 21:2994.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Z, Zhang X, Liang J, et al. Short-term outcomes for laparoscopy-assisted distal gastrectomy for body mass index ≥30 patients with gastric cancer. J Surg Res 2015; 195:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sugimoto M, Kinoshita T, Shibasaki H, et al. Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer. Surg Endosc 2013; 27:4291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Son SY, Jung DH, Lee CM, et al. Laparoscopic gastrectomy versus open gastrectomy for gastric cancer in patients with body mass index of 30 kg/m2 or more. Surg Endosc 2015; 29:2126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nunobe S, Hiki N, Fukunaga T, et al. Previous laparotomy is not a contraindication to laparoscopy-assisted gastrectomy for early gastric cancer. World J Surg 2008; 32:1466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woo Y, Hyung WJ, Kim HI, et al. Minimizing hepatic trauma with a novel liver retraction method: a simple liver suspension using gauze suture. Surg Endosc 2011; 25:3939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saeki H, Oki E, Kawano H, et al. Newly developed liver-retraction method for laparoscopic gastric surgery using a silicone disc: the φ-shaped technique. J Am Coll Surg 2013; 216:e43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JH, Tanaka E, Woo Y, et al. Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery. J Surg Oncol 2017; 116:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong SH, Kim JW, Lee HJ, et al. The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy. Ann Surg Oncol 2009; 16:3252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park DJ, Kim YW, Yang HK, et al. Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial). Br J Surg 2021; 108:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhu CC, Cao H, Berlth F, et al. Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher? Gastric Cancer 2019; 22:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uyama I, Ogiwara H, Takahara T, et al. Laparoscopic and minilaparotomy proximal gastrectomy and esophagogastrostomy: technique and case report. Surg Laparosc Endosc 1995; 5:487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung DH, Ahn SH, Park DJ, Kim HH. Proximal Gastrectomy for Gastric Cancer. J Gastric Cancer 2015; 15:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanioka T, Waratchanont R, Fukuyo R, et al. Surgical and nutritional outcomes of laparoscopic proximal gastrectomy versus total gastrectomy: a meta-analysis. Surg Endosc 2020; 34:1061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kukar M, Gabriel E, Ben-David K, Hochwald SN. Laparoscopic proximal gastrectomy for gastric neoplasms. J Surg Oncol 2018; 118:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdikarim I, Cao XY, Li SZ, et al. Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas. World J Gastroenterol 2015; 21:13339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong-Chong N, Kehlet H, Grantcharov TP. Outcomes From an Enhanced Recovery Program for Laparoscopic Gastric Surgery. Surg Laparosc Endosc Percutan Tech 2016; 26:e50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li HZ, Chen JX, Zheng Y, Zhu XN. Laparoscopic-assisted versus open radical gastrectomy for resectable gastric cancer: Systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials. J Surg Oncol 2016; 113:756.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hakkenbrak NAG, Jansma EP, van der Wielen N, et al. Laparoscopic versus open distal gastrectomy for gastric cancer: A systematic review and meta-analysis. Surgery 2022; 171:1552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YW, Baik YH, Yun YH, et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 2008; 248:721.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YW, Yoon HM, Yun YH, et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301). Surg Endosc 2013; 27:4267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hendriksen BS, Brooks AJ, Hollenbeak CS, et al. The Impact of Minimally Invasive Gastrectomy on Survival in the USA. J Gastrointest Surg 2020; 24:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwon IG, Son T, Kim HI, Hyung WJ. Fluorescent Lymphography-Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer. JAMA Surg 2019; 154:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cianchi F, Indennitate G, Paoli B, et al. The Clinical Value of Fluorescent Lymphography with Indocyanine Green During Robotic Surgery for Gastric Cancer: a Matched Cohort Study. J Gastrointest Surg 2020; 24:2197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coratti A, Fernandes E, Lombardi A, et al. Robot-assisted surgery for gastric carcinoma: Five years follow-up and beyond: A single western center experience and long-term oncological outcomes. Eur J Surg Oncol 2015; 41:1106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakauchi M, Suda K, Susumu S, et al. Comparison of the long-term outcomes of robotic radical gastrectomy for gastric cancer and conventional laparoscopic approach: a single institutional retrospective cohort study. Surg Endosc 2016; 30:5444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HI, Han SU, Yang HK, et al. Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma. Ann Surg 2016; 263:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JM, Kim HI, Han SU, et al. Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy. Eur J Surg Oncol 2016; 42:1944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cianchi F, Indennitate G, Trallori G, et al. Robotic vs laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer: a retrospective comparative mono-institutional study. BMC Surg 2016; 16:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu LD, Li XF, Wang XY, Guo TK. Robotic versus Laparoscopic Gastrectomy for Gastric Carcinoma: a Meta-Analysis of Efficacy and Safety. Asian Pac J Cancer Prev 2016; 17:4327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu J, Zheng CH, Xu BB, et al. Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial. Ann Surg 2021; 273:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ojima T, Nakamura M, Hayata K, et al. Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2021; 156:954.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uedo N, Iishi H, Tatsuta M, et al. Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer 2006; 9:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahn JY, Jung HY, Choi KD, et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc 2011; 74:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shoda K, Ichikawa D, Arita T, et al. Risk Stratification According to the Total Number of Factors That Meet the Indication Criteria for Radical Lymph Node Dissection in Patients with Early Gastric Cancer at Risk for Lymph Node Metastasis. Ann Surg Oncol 2016; 23:792.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 109436 Version 11.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8180768" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Laparoscopy-assisted Billroth I gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25339802" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Minimally invasive surgery in gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34023140" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Systematic review and updated network meta-analysis of randomized controlled trials comparing open, laparoscopic-assisted, and robotic distal gastrectomy for early and locally advanced gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17197967" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27115899" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26352529" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30730546" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27718137" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31757656" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30128720" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase II clinical trial, KLASS 03.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32815991" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27287914" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24651893" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Oncologic outcomes of laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective cohort study from China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26903580" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31135850" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34668963" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30829698" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32816629" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35857305" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26170158" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25791064" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Minimally invasive gastrectomy for cancer: current utilization in US academic medical centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26961133" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Minimally invasive surgery for gastric cancer: the American experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25631063" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32737637" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20224369" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23192297" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23610716" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Totally laparoscopic distal gastrectomy after learning curve completion: comparison with laparoscopy-assisted distal gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25861520" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Lessons learned from a comparative analysis of surgical outcomes of and learning curves for laparoscopy-assisted distal gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24470012" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25481705" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The learning curve associated with laparoscopic total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24687152" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Risk factors and learning curve associated with postoperative morbidity of laparoscopic total gastrectomy for gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25617970" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Short-term outcomes for laparoscopy-assisted distal gastrectomy for body mass index≥30 patients with gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23793806" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25480601" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Laparoscopic gastrectomy versus open gastrectomy for gastric cancer in patients with body mass index of 30 kg/m2 or more.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18340481" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Previous laparotomy is not a contraindication to laparoscopy-assisted gastrectomy for early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21656069" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Minimizing hepatic trauma with a novel liver retraction method: a simple liver suspension using gauze suture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23535162" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Newly developed liver-retraction method for laparoscopic gastric surgery using a silicone disc: theφ-shaped technique.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28628714" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19639365" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34487147" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30778800" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8612000" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Laparoscopic and minilaparotomy proximal gastrectomy and esophagogastrostomy: technique and case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26161281" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Proximal Gastrectomy for Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31932938" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Surgical and nutritional outcomes of laparoscopic proximal gastrectomy versus total gastrectomy: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29920681" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Laparoscopic proximal gastrectomy for gastric neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26715818" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27258917" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Outcomes From an Enhanced Recovery Program for Laparoscopic Gastric Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27076039" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Laparoscopic-assisted versus open radical gastrectomy for resectable gastric cancer: Systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35101328" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Laparoscopic versus open distal gastrectomy for gastric cancer: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18948798" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23793805" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Long-term outcomes of laparoscopy-assisted distal gastrectomy for early gastric cancer: result of a randomized controlled trial (COACT 0301).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31152343" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The Impact of Minimally Invasive Gastrectomy on Survival in the USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30427990" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Fluorescent Lymphography-Guided Lymphadenectomy During Robotic Radical Gastrectomy for Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31485904" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The Clinical Value of Fluorescent Lymphography with Indocyanine Green During Robotic Surgery for Gastric Cancer: a Matched Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25796984" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Robot-assisted surgery for gastric carcinoma: Five years follow-up and beyond: A single western center experience and long-term oncological outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27129542" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Comparison of the long-term outcomes of robotic radical gastrectomy for gastric cancer and conventional laparoscopic approach: a single institutional retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26020107" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27514719" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27646414" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Robotic vs laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer: a retrospective comparative mono-institutional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27797239" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Robotic versus Laparoscopic Gastrectomy for Gastric Carcinoma: a Meta-Analysis of Efficacy and Safety.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32889876" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34468701" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Short-term Outcomes of Robotic Gastrectomy vs Laparoscopic Gastrectomy for Patients With Gastric Cancer: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16767363" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Longterm outcomes after endoscopic mucosal resection for early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21741645" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27613556" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Risk Stratification According to the Total Number of Factors That Meet the Indication Criteria for Radical Lymph Node Dissection in Patients with Early Gastric Cancer at Risk for Lymph Node Metastasis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
